CN1044321C - 治疗妇女更年期综合征的药物组合物 - Google Patents
治疗妇女更年期综合征的药物组合物 Download PDFInfo
- Publication number
- CN1044321C CN1044321C CN94118270A CN94118270A CN1044321C CN 1044321 C CN1044321 C CN 1044321C CN 94118270 A CN94118270 A CN 94118270A CN 94118270 A CN94118270 A CN 94118270A CN 1044321 C CN1044321 C CN 1044321C
- Authority
- CN
- China
- Prior art keywords
- vitamin
- accounts
- content
- composition
- composition weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94118270A CN1044321C (zh) | 1994-11-18 | 1994-11-18 | 治疗妇女更年期综合征的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94118270A CN1044321C (zh) | 1994-11-18 | 1994-11-18 | 治疗妇女更年期综合征的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1123145A CN1123145A (zh) | 1996-05-29 |
CN1044321C true CN1044321C (zh) | 1999-07-28 |
Family
ID=5038728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94118270A Expired - Lifetime CN1044321C (zh) | 1994-11-18 | 1994-11-18 | 治疗妇女更年期综合征的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1044321C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005027929A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen |
CN101422602B (zh) * | 2008-12-08 | 2011-02-09 | 济南老来寿生物技术有限公司 | 一种改善女性更年期症状的功能性食品 |
US9306654B2 (en) * | 2014-01-10 | 2016-04-05 | Qualcomm Incorporated | Opportunistic active interference cancellation using RX diversity antenna |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1036328A (zh) * | 1987-12-22 | 1989-10-18 | 阿克佐公司 | 治疗更年期疾病和骨质疏松症的药物剂量单位 |
CN1120311A (zh) * | 1993-04-07 | 1996-04-10 | 阿斯特拉公司 | 含亲脂药的药物组合物 |
-
1994
- 1994-11-18 CN CN94118270A patent/CN1044321C/zh not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1036328A (zh) * | 1987-12-22 | 1989-10-18 | 阿克佐公司 | 治疗更年期疾病和骨质疏松症的药物剂量单位 |
CN1120311A (zh) * | 1993-04-07 | 1996-04-10 | 阿斯特拉公司 | 含亲脂药的药物组合物 |
Non-Patent Citations (1)
Title |
---|
中药妇产科杂志 1990.4.1 林守清,葛秦生北京 * |
Also Published As
Publication number | Publication date |
---|---|
CN1123145A (zh) | 1996-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Notelovitz | Estrogen replacement therapy: indications, contraindications, and agent selection | |
US11896602B2 (en) | Method for preventing pregnancy | |
CN1137691C (zh) | 基于天然雌激素的多相避孕制剂 | |
EP0424954B1 (en) | Pharmaceutical composition for treatment of osteoporosis | |
US7683047B2 (en) | Treatment of conditions relating to hormone deficiencies by administration of progestins | |
KR100913910B1 (ko) | 호르몬 보충 요법용 드로스피렌온 | |
DE69532927T2 (de) | Cyclophasiges hormonverfahren das antiprogestin und progestin enthält | |
JPS6245845B2 (zh) | ||
EP1260225A1 (en) | A pharmaceutical composition for use in hormone replacement therapy | |
CN102740891B (zh) | 载体组合物 | |
BG62383B1 (bg) | Метод за хормонзаместващо лечение | |
DE69901250T2 (de) | 7.alpha.-methyl 19-nortestosteron undecanoat mit androgenischer aktivität | |
JP2007511533A (ja) | 段階的エストロゲン避妊薬 | |
CN1044321C (zh) | 治疗妇女更年期综合征的药物组合物 | |
RU2188641C2 (ru) | Новые гормональные лекарственные препараты и их применение для коррекции эстрогенной недостаточности | |
Ball et al. | Comparison of two triphasic contraceptives with different progestogens: effects on metabolism and coagulation proteins | |
JP2942560B2 (ja) | エストロゲン欠乏症治療用組成物 | |
KR20040063950A (ko) | 아스코르베이트, 리신, 프롤린 및 기타 물질을 함유하는에스트로겐 및 기타 호르몬의 조성물 | |
Edman | Estrogen replacement therapy | |
KR100550889B1 (ko) | 스테로이드 함유 플라스터, 그 제조 방법, 및 그 용도 | |
JP3657285B2 (ja) | 皮膚外用組成物 | |
JPH06298645A (ja) | 高脂血症治療・予防剤 | |
US5591732A (en) | Medicament for influencing the degree of activation of the central nervous system | |
RU2282449C2 (ru) | Композиция с эстрогеном и другими гормонами, содержащая аскорбат, лизин, пролин и другие вещества | |
CN1074279C (zh) | 苯甲酸雌二醇凝胶剂及其制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Applicant after: Leibo pharmaceutical factory of Beijing Applicant before: Yu Shuhui Applicant before: Gao Shouzheng Applicant before: Sun Nianhu |
|
CB03 | Change of inventor or designer information |
Inventor after: Yu Shuhui Inventor after: Gao Shouzheng Inventor after: Sun Nianhu Inventor before: Yu Shuhui Inventor before: Gao Shouzheng Inventor before: Sun Nianhu Inventor before: Zhang Songlan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YU SHUHUI; GAO SHOUZHENG; SUN NIANHU; ZHANG SONGLAN TO: YU SHUHUI; GAO SHOUZHENG; SUN NIANHU |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: BEIJING LEIBO PHARMACY CO., LTD. Free format text: FORMER NAME OR ADDRESS: BEIJING LEIBO PHARMACEUTICAL FACTORY |
|
CP03 | Change of name, title or address |
Address after: 100044 Beijing Haidian District City Hospital No. 1 Zizhuyuan Road No. 6 Building 21 layer renjishanzhuang Patentee after: Beijing budding Pharmaceutical Co., Ltd. Address before: 100045 Beijing city Xicheng District Yuetan Nan Street 1 Patentee before: Leibo Pharmaceutical Plant, Beijing |
|
ASS | Succession or assignment of patent right |
Owner name: HEBEI HENGLI GROUP CO.,LTD. Free format text: FORMER OWNER: BEIJING LEIBO PHARMACY CO., LTD. Effective date: 20051118 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20051118 Address after: 054109 Shahe City, Hebei province Luanxie Industrial Zone Patentee after: Hebei Hengli Group Co., Ltd. Address before: 100044 Beijing Haidian District City Hospital No. 1 Zizhuyuan Road No. 6 Building 21 layer renjishanzhuang Patentee before: Beijing budding Pharmaceutical Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: BEIJING KANG RAPID PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: HEBEI HENGLI GROUP CO.,LTD. Effective date: 20071214 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20071214 Address after: Beijing City, Daxing District science and Technology Park of Zhongguancun biological medicine industry base Yongda Road No. 37 Patentee after: Beijing Kangbide Pharmaceutical Co., Ltd. Address before: Shahe City, Hebei province Luanxie Industrial Zone Patentee before: Hebei Hengli Group Co., Ltd. |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20141118 Granted publication date: 19990728 |